4-Hydroxyderricin from Angelica keiskei promotes the stability of BRCA1 in triple-negative breast cancer cells through inhibition of cathepsin S
Phytochemistry · 2026
DOI: 10.1016/j.phytochem.2026.114805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemistry, 2026. Verfasst von Isoo Youn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, 03760, South Korea. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Angelica, BRCA1 Protein, Cathepsins. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Ministry of Education, National Research Foundation of Korea, Military Institute of Science and Technology.
Abstract (Originalsprache)
Breast cancer susceptibility gene 1 (BRCA1), a tumor suppressor protein, is closely associated with ovarian and breast cancers. Previously, cathepsin S (CTSS) was reported to prevent BRCA1-mediated apoptosis, contributing to chemoresistance in TNBC. In this study, we screened the CTSS inhibitory activity of 107 pure compounds derived from plant materials and identified 4-hydroxyderricin (12) from Angelica keiskei as a potent CTSS inhibitor. Compound 12 increased BRCA1 stability in TNBC cells in a CTSS-dependent manner. In an in vivo TNBC xenograft mouse model, combination treatment with paclitaxel and compound 12 significantly increased BRCA1 stability, reduced the final tumor weight, and decreased the number of Ki-67-positive proliferative cells. Our findings suggest that combination therapy with compound 12 can enhance BRCA1 function and improve chemotherapeutic efficacy. This study highlights CTSS inhibition as a promising therapeutic strategy for TNBC patients with wild-type BRCA1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, 03760, South Korea.
- College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae, Gyeongnam, 50834, South Korea.
- Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, 03760, South Korea. Electronic address: yslee0425@ewha.ac.kr.
- Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, 03760, South Korea. Electronic address: yuny@ewha.ac.kr.
Förderung
- Ministry of Education
- National Research Foundation of Korea
- Military Institute of Science and Technology
Zitieren
APA
Youn, I., Oh, H., Kim, T., Park, S., Kil, Y. S., Kang, S., Lee, Y. S., & Seo, E. K. (2026). 4-Hydroxyderricin from Angelica keiskei promotes the stability of BRCA1 in triple-negative breast cancer cells through inhibition of cathepsin S. Phytochemistry. https://doi.org/10.1016/j.phytochem.2026.114805
Vancouver
Youn I, Oh H, Kim T, Park S, Kil YS, Kang S, et al. 4-Hydroxyderricin from Angelica keiskei promotes the stability of BRCA1 in triple-negative breast cancer cells through inhibition of cathepsin S. Phytochemistry. 2026. doi:10.1016/j.phytochem.2026.114805
BibTeX
@article{Youn2026,
author = {Youn, Isoo and Oh, Hyelim and Kim, Taeeun and Park, Sumin and Kil, Yun-Seo and Kang, Soosung and Lee, Yun-Sil and Seo, Eun Kyoung},
title = {4-Hydroxyderricin from Angelica keiskei promotes the stability of BRCA1 in triple-negative breast cancer cells through inhibition of cathepsin S},
journal = {Phytochemistry},
year = {2026},
doi = {10.1016/j.phytochem.2026.114805}
}
EUVIMED